Cargando…
The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer
Background: The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is hyperactivated in lung cancer and regulates a broad range of cellular processes, including proliferation, survival, angiogenesis, and metastasis. Thus PI3K is considered a promising target for therapy. To date, PI3K inhibi...
Autores principales: | Dong, Chao, Chen, Yin, Li, Hongjian, Yang, Yi, Zhang, Hongtao, Ke, Kunbin, Shi, Xi-Nan, Liu, Xu, Li, Ling, Ma, Jing, Kung, Hsiang-Fu, Chen, Ceshi, Lin, Marie Chia-mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643147/ https://www.ncbi.nlm.nih.gov/pubmed/31337981 http://dx.doi.org/10.7150/ijbs.32625 |
Ejemplares similares
-
Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells
por: Dong, Chao, et al.
Publicado: (2017) -
Flupentixol tartrate
por: Yamuna, Thammarse S., et al.
Publicado: (2014) -
Association between cumulative exposure periods of flupentixol or any antipsychotics and risk of lung cancer
por: Chai, Yi, et al.
Publicado: (2023) -
Melitracen and flupentixol (deanxit) use disorder in Lebanon
por: El Zahran, Tharwat, et al.
Publicado: (2023) -
Case report: Extrapontine myelinolysis combined with flupentixol- and melitracen-induced dysphagia
por: Zhao, Zhihong, et al.
Publicado: (2023)